Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7184)
All Articles published online
|
Publishing Process of This Article
|
Feb 27, 2015 (publication date) through Nov 9, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ridruejo E. Antiviral treatment for chronic hepatitis B in renal transplant patients. World J Hepatol 2015; 7(2): 189-203 [PMID: 25729474 DOI: 10.4254/wjh.v7.i2.189] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i2/189.htm |
| Number | Citing Articles |
| 1 |
Martina Vitrone, Domenico Iossa, Luca Rinaldi, Pia Clara Pafundi, Rosa Molaro, Antonio Parrella, Roberto Andini, Enrico Ragone, Ciro Maiello, Rosa Zampino, Emanuele Durante-Mangoni. Hepatitis B virus reactivation after heart transplant: Incidence and clinical impact. Journal of Clinical Virology 2017; 96: 54 doi: 10.1016/j.jcv.2017.09.011
|
| 2 |
Jeonghwan Lee, Jang-Hee Cho, Jong Soo Lee, Dong-Won Ahn, Chan-Duck Kim, Curie Ahn, In Mok Jung, Duck Jong Han, Chun Soo Lim, Yon Su Kim, Young Hoon Kim, Jung Pyo Lee. Pretransplant Hepatitis B Viral Infection Increases Risk of Death After Kidney Transplantation. Medicine 2016; 95(21): e3671 doi: 10.1097/MD.0000000000003671
|
| 3 |
Anil Arora, Anil C. Anand, Ashish Kumar, Shivaram P. Singh, Rakesh Aggarwal, Radha K. Dhiman, Shyam Aggarwal, Seema Alam, Pradeep Bhaumik, Vinod K. Dixit, Ashish Goel, Bhabadev Goswami, Ashok Kumar, Manoj Kumar, Kaushal Madan, Natarajan Murugan, Aabha Nagral, Amarender S. Puri, Padaki N. Rao, Neeraj Saraf, Vivek A. Saraswat, Sanjeev Sehgal, Praveen Sharma, Koticherry T. Shenoy, Manav Wadhawan. INASL Guidelines on Management of Hepatitis B Virus Infection in Patients receiving Chemotherapy, Biologicals, Immunosupressants, or Corticosteroids. Journal of Clinical and Experimental Hepatology 2018; 8(4): 403 doi: 10.1016/j.jceh.2018.06.010
|
| 4 |
Kazuharu Suzuki, Goki Suda, Yoshiya Yamamoto, Ken Furuya, Masaru Baba, Megumi Kimura, Osamu Maehara, Tomoe Shimazaki, Koji Yamamoto, Taku Shigesawa, Akihisa Nakamura, Masatsugu Ohara, Naoki Kawagishi, Masato Nakai, Takuya Sho, Mitsuteru Natsuizaka, Kenichi Morikawa, Koji Ogawa, Naoya Sakamoto. Entecavir treatment of hepatitis B virus‐infected patients with severe renal impairment and those on hemodialysis. Hepatology Research 2019; 49(11): 1294 doi: 10.1111/hepr.13399
|
| 5 |
Yu-Lien Tsai, Meng-Hsuan Chung, Niang-Cheng Lin, Cheng-Yen Chen, Yao-Ping Lin, Ming-Tsun Tsai, Hsin-Lin Tsai, Yee-An Chen, Shuo-Ming Ou, Chi-Jen Chu, Tsai-Hung Wu, Chang-Youh Tsai. The Risk Factors and Clinical Outcomes in Hepatitis B Seropositive and Seronegative Renal Transplant Patients. American Journal of Nephrology 2024; 55(4): 477 doi: 10.1159/000538231
|
| 6 |
Pietro Lampertico, Kosh Agarwal, Thomas Berg, Maria Buti, Harry L.A. Janssen, George Papatheodoridis, Fabien Zoulim, Frank Tacke. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. Journal of Hepatology 2017; 67(2): 370 doi: 10.1016/j.jhep.2017.03.021
|
| 7 |
INASL-ISN Joint Position Statements on Management of Patients with Simultaneous Liver and Kidney Disease. Journal of Clinical and Experimental Hepatology 2021; 11(3): 354 doi: 10.1016/j.jceh.2020.09.005
|
| 8 |
U. Eisenberger. Wartelistenmanagement vor Nierentransplantation. Der Nephrologe 2018; 13(3): 146 doi: 10.1007/s11560-018-0237-3
|
| 9 |
Goki Suda, Masaru Baba, Yoshiya Yamamoto, Takuya Sho, Koji Ogawa, Megumi Kimura, Shunichi Hosoda, Sonoe Yoshida, Akinori Kubo, Qingjie Fu, Zijian Yang, Yoshimasa Tokuchi, Takashi Kitagataya, Osamu Maehara, Shunsuke Ohnishi, Ren Yamada, Masatsugu Ohara, Naoki Kawagishi, Mitsuteru Natsuizaka, Masato Nakai, Kenichi Morikawa, Ken Furuya, Kazuharu Suzuki, Takaaki Izumi, Takashi Meguro, Katsumi Terashita, Jun Ito, Tomoe Kobayashi, Izumi Tsunematsu, Naoya Sakamoto. Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation‐related hepatitis. Journal of Medical Virology 2023; 95(2) doi: 10.1002/jmv.28452
|
| 10 |
Deepak Pradhan, Prativa Biswasroy, Amit Goyal, Goutam Ghosh, Goutam Rath. Recent Advancement in Nanotechnology-Based Drug Delivery System Against Viral Infections. AAPS PharmSciTech 2021; 22(1) doi: 10.1208/s12249-020-01908-5
|
| 11 |
Kiran Gajurel, Jack T. Stapleton. Hepatitis Viruses in Kidney Transplantation. Seminars in Nephrology 2016; 36(5): 386 doi: 10.1016/j.semnephrol.2016.05.015
|
| 12 |
Bircan Kayaaslan, Rahmet Guner. Adverse effects of oral antiviral therapy in chronic hepatitis B. World Journal of Hepatology 2017; 9(5): 227-241 doi: 10.4254/wjh.v9.i5.227
|
| 13 |
C. Ng, R. Danguilan, G. Pamugas, E. Que. Outcomes of Renal Allograft Recipients With Hepatitis B From January 2000 to December 2010. Transplantation Proceedings 2018; 50(10): 3242 doi: 10.1016/j.transproceed.2018.07.028
|
| 14 |
E. Durante‐Mangoni, M. Vitrone, A. Parrella, R. Andini, D. Iossa, E. Ragone, E. Falco, C. Maiello, R. Utili, R. Zampino. Efficacy and safety of tenofovir, entecavir, and telbivudine for chronic hepatitis B in heart transplant recipients. Transplant Infectious Disease 2016; 18(3): 319 doi: 10.1111/tid.12525
|
| 15 |
Berfu Korucu, Sena Ulu, Ozkan Gungor. Current Approach to Renal Transplantation Candidates and Potential Donors with Viral Hepatitis. PRILOZI 2023; 44(1): 135 doi: 10.2478/prilozi-2023-0015
|